Position in BIAF
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,413
-$31,876 QoQ
Shares Held
46,725
+0.0% QoQ
Ownership
8.65%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 20 holders
Holding Since
Sep 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIAF Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026UBS Group AG holds $4,492,966,338 across 42 Diagnostics & Research names. BIAF ranks #39 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,521,208 | $1,264,032,836 | |
| 2 | DHR |
Danaher Corp /De/
|
3,243,524 | $617,826,447 | |
| 3 | WAT |
Waters Corp /De/
|
694,851 | $260,596,916 | |
| 4 | A |
Agilent Technologies, Inc.
|
1,574,629 | $209,157,967 | |
| 5 | RVTY |
Revvity, Inc.
|
1,864,464 | $207,440,262 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
364,663 | $191,973,186 | |
| 7 | DGX |
Quest Diagnostics Inc
|
888,906 | $188,403,625 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
128,025 | $163,553,216 |
All Filings in BIAF
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,413 | 4,204 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $35,289 | 9,214 | Shares | Defined | 2026-05-05 | |
| 2025-09-30 | $423 | 143 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6 | 24 | Shares | Defined | 2025-08-14 | |
| 2024-06-30 | $20,716 | 9,591 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $75 | 65 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $173 | 95 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,553 | 2,409 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $10,529 | 6,581 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $14,325 | 4,923 | Shares | Sole | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||